Janel Corp

Janel Corp is a U.S.-based holding company with operating subsidiaries in logistics, life sciences, and manufacturing. It creates value by allocating capital across these businesses, supporting organic growth, and acquiring companies that fit its portfolio and management style.

3,4 %

31,3 %

2,7 %

+13,2 %

0.74

0.70

— Janel Corp
%
Logistics services85% Non-asset-based cargo transportation management, including forwarding, brokerage, warehousing, trucking, and accessorial charges.
Life sciences products10% Protein-related research and diagnostic reagents sold to scientific and clinical customers.
Manufacturing5% Industrial/manufacturing activities and related products within the portfolio.

Janel serves a broad logistics customer base that uses freight forwarding, customs brokerage, and warehousing to move...

  • Logistics shippersprimary

    Businesses shipping freight domestically and internationally that buy forwarding, brokerage, warehousing, and trucking services to reduce complexity and transit time.

  • Academic and research institutionssecondary

    Universities and research labs buying protein-related reagents and tools for life science research.

  • Diagnostic and pharmaceutical customerssecondary

    Clinical and pharma buyers using reagents and scientific products for testing, development, and research workflows.

  • Private-label / re-label customersemerging

    Customers that use Janel's scientific expertise and production capabilities to source products under their own brand.

Janel is headquartered in New York and operates primarily in the United States, where it employed all 353 full-time...

  • Headquartered in New York, New York
  • Operations and employees are concentrated in the United States
  • Logistics network reaches many trading countries worldwide
  • Cross-border freight exposure ties results to global trade flows
  • No country-level revenue split was disclosed in the excerpts

Janel's strategy centers on disciplined capital allocation, organic growth, and acquisitions that add stable earnings...

01
Acquisitions and portfolio expansionmedium-term

Janel expects growth from buying businesses within existing segments or entering new ones.

02
Operational improvementshort-term

Better operating design and processes can lift profitability and free capital for growth.

03
Product innovation in life sciencesmedium-term

New products can broaden the research toolkit and deepen customer relationships.

Janel's growth model depends heavily on acquisitions, so deal sourcing, integration, and valuation discipline are...

high

Acquisition execution and valuation risk

Growth depends on buying businesses at reasonable prices and integrating them successfully.

Scope
Could reduce profitability if targets underperform or synergies do not materialize.
Materiality
high
high

Geopolitical and trade disruption

Logistics volumes and routing can be affected by war, terrorism, and border/security changes.

Scope
Most relevant to freight forwarding and cross-border shipments.
Materiality
high
high

Cybersecurity and IT systems risk

The company relies on internal and third-party systems to manage shipments and sensitive data.

Scope
Could cause service interruptions, liability, and reputational damage.
Materiality
high
medium

Third-party provider dependence

Janel is non-asset-based and relies on carriers, agents, and vendors to execute shipments.

Scope
Service quality and margins depend on external partners.
Materiality
medium
Acquisition-related intangible assets
Can materially affect operating income and net income after acquisitions
Organic revenue and gross profit measures
Important for comparing periods, especially after deal activity
Non-GAAP adjusted operating income
Can influence investor perception of core operating performance

: 28/04/2026